A team of Chinese researchers has developed two new genome editing technologies, known collectively as Programmable Chromosome Engineering (PCE) systems.

This is particularly true in biotechnology, where AI models power breakthroughs in drug discovery, precision medicine, gene editing, food security, and many other research areas.